Last $91.55 USD
Change Today -2.24 / -2.39%
Volume 13.4M
GILD On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
As of 8:10 PM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gregg H. Alton

Executive Vice President of Corporate & Medical Affairs and Secretary, Gilead Sciences Inc.
AgeTotal Calculated CompensationThis person is connected to 54 board members in 2 different organizations across 4 different industries.

See Board Relationships
48--

Background*

Mr. Gregg H. Alton is an Executive Vice President of Corporate and Medical Affairs at Gilead Sciences Inc. and Gilead Palo Alto, Inc. Mr. Alton served as Senior Vice President of Gilead Sciences Inc. from July 2005 to August 3, 2009 and also served as its General Counsel since 2000. He served as Vice President at Gilead Sciences Inc. from 2001 to July 2005 and served as its Associate General Counsel from 1999 to 2001. From 2000 to 2009, Mr. Alton served various positions ...

Read Full Background

Corporate Headquarters*

333 Lakeside Drive
Foster City, California 94404

United States

Phone: 650-574-3000
Fax: 650-578-9264

Board Members Memberships*

Director
2008-2013
Former Independent Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
2013-Present
Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee

Education*

JD
The Leland Stanford Junior University
BA
University of California Berkeley
JD
Stanford University Law school

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GILD:US $91.55 USD -2.24

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GILEAD SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.